BRAINLIFE.ORG
|
|
|
|
|
Current
Neuro-Oncology
|
|
|
|
Volume
26 Number 8
30 April 2024
|
|
|
|
Home
>
Publications
>
Current
Neuro-Oncology >
Volume
26, Year 2024 >
Number
8, 30 April
|
|
|
|
|
|
Lowenstein PR, Varela ML, Castro MG.
Three
recent breakthroughs in CAR T cells for the treatment of
glioblastoma: Is it the light at the end of the tunnel?
Mol
Ther. 2024 Apr 16:S1525-0016(24)00235-1. doi:
10.1016/j.ymthe.2024.04.018. PMID:
38631354. Comment˰ ˍ
Related
articles:
|
|
-Choi BD, Gerstner ER, Frigault
MJ, Leick MB, Mount CW, Balaj L, Nikiforow S, Carter BS, Curry WT,
Gallagher K, Maus MV.
Intraventricular
CARv3-TEAM-E T Cells in Recurrent Glioblastoma.
N
Engl J Med.
2024 Mar 13;390(14):1290-1298. doi:
10.1056/NEJMoa2314390. PMID:
38477966. Interventional study. ˍ
|
|
-Bagley SJ, Logun M, Fraietta
JA, Wang X, Desai AS, Bagley LJ, Nabavizadeh A, Jarocha D, Martins
R, Maloney E, Lledo L, Stein C, Marshall A, Leskowitz R, Jadlowsky
JK, Christensen S, Oner BS, Plesa G, Brennan A, Gonzalez V, Chen
F, Sun Y, Gladney W, Barrett D, Nasrallah MP, Hwang WT, Ming GL,
Song H, Siegel DL, June CH, Hexner EO, Binder ZA, O'Rourke
DM.
Intrathecal
bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent
glioblastoma: phase 1 trial interim results.
Nat
Med. 2024
Mar 13. doi:
10.1038/s41591-024-02893-z. PMID:
38480922. Interventional study˰ ˍ
|
|
-Brown CE, Hibbard JC, Alizadeh
D, Blanchard MS, Natri HM, Wang D, Ostberg JR, Aguilar B, Wagner
JR, Paul JA, Starr R, Wong RA, Chen W, Shulkin N, Aftabizadeh M,
Filippov A, Chaudhry A, Ressler JA, Kilpatrick J, Myers-McNamara
P, Chen M, Wang LD, Rockne RC, Georges J, Portnow J, Barish ME,
D'Apuzzo M, Banovich NE, Forman SJ, Badie B.
Locoregional
delivery of IL-13Rα2-targeting CAR-T cells in recurrent
high-grade glioma: a phase 1 trial.
Nat
Med. 2024
Mar 7. doi:
10.1038/s41591-024-02875-1. PMID:
38454126. Interventional study. ˍ
|
|
|
|
Okon II, Musharaf I, Chaurasia B, Qadri HM, Kankam SB,
Lucero-Prisno DE 3rd.
Tuning in:
musical resilience in awake craniotomy for brain tumor
resection.
Neurosurg Rev. 2024 Apr 16;47(1):157. doi:
10.1007/s10143-024-02385-1. PMID: 38622378. Correspondence˰
ˍ
|
|
|
|
Zhu N, Chen S, Jin Y, Wang M, Fang L, Xue L, Hua D, Zhang Z, Jia
M, Hao M, Zhang C.
Enhancing
Glioblastoma Immunotherapy with Integrated Chimeric Antigen
Receptor T Cells through the Re-Education of Tumor-Associated
Microglia and Macrophages.
ACS
Nano. 2024 Apr 16. doi:
10.1021/acsnano.4c00050. PMID:
38626338. Laboratory investigation˰
ˍ
|
|
|
|
*Alhaj AK, Burhamah T, Mohammad F, Almutawa M, Dashti F, Almurshed
M, Behzad S, Snuderl M, Hasan A.
Are
the Radiological and Molecular Features of Pediatric
Medulloblastomas Valuable Prognostic Indicators? A 10-year
Retrospective Review in the Middle East.
World
Neurosurg. 2024 Apr 17:S1878-8750(24)00620-X. doi:
10.1016/j.wneu.2024.04.057. PMID:
38636638. Observational study. ˍ
|
|
|
|
Gately L, Mesía C, Sepúlveda JM, Del Barco S, Pineda
E, Gironés R, Fuster J, Dumas M, Gill S, Navarro LM,
Herrero A, Dowling A, de Las Peñas R, Vaz MA, Alonso M,
Lwin Z, Harrup R, Peralta S, Long A, Perez-Segura P, Ahern E,
Garate CO, Wong M, Campbell R, Cuff K, Jennens R, Gallego O,
Underhill C, Martinez-Garcia M, Covela M, Cooper A, Brown S,
Rosenthal M, Torres J, Collins IM, Gibbs P, Balana C.
Exploring
management and outcomes of elderly patients with glioblastoma
using data from two randomised trials (GEINO1401/EX-TEM).
J
Neurooncol. 2024 Apr 17. doi:
10.1007/s11060-024-04668-5. PMID:
38630385. Observational study˰
ˍ
|
|
|
|
Dağdelen D, Zincir H.
Effects of
dependent care theory-based post-surgical home care intervention
on self-care, symptoms, and caregiver burden in patients with
primary brain tumor and their caregivers: a randomized controlled
trial.
Support
Care Cancer. 2024 Apr 18;32(5):296. doi:
10.1007/s00520-024-08488-1. PMID:
38635060. Interventional study. ˍ
|
|
|
|
Low JCM, Cao J, Hesse F, Wright AJ, Tsyben A, Alshamleh I, Mair R,
Brindle KM.
Deuterium metabolic imaging
differentiates glioblastoma metabolic subtypes and detects early
response to chemoradiotherapy.
Cancer
Res. 2024 Apr 18. doi:
10.1158/0008-5472.CAN-23-2552. PMID:
38635885. Laboratory investigation.
ˍ
|
|
|
|
Rolling CC, Mohme M, Bokemeyer C, Westphal M, Riethdorf S, Lamszus
K, Pantel K, Klingler F, Langer F.
Circulating
Tumor Cells and Thromboembolic Events in Patients with
Glioblastoma.
Hamostaseologie.
2024 Apr 18. doi:
10.1055/a-2251-6766. PMID:
38636546. Observational study˰
ˍ
|
|
|
|
Tobochnik S, Regan MS, Dorotan MKC, Reich D, Lapinskas E, Hossain
MA, Stopka S, Santagata S, Murphy MM, Arnaout O, Bi WL, Antonio
Chiocca E, Golby AJ, Mooney MA, Smith TR, Ligon KL, Wen PY, Agar
NYR, Lee JW.
Pilot trial of perampanel
on peritumoral hyperexcitability and clinical outcomes in newly
diagnosed high-grade glioma.
medRxiv
[Preprint]. 2024 Apr 18:2024.04.11.24305666. doi:
10.1101/2024.04.11.24305666. PMID:
38645003. Interventional study. ˍ
|
|
|
|
*Oztep Eskici S, Yilmaz EB.
Prognostic
significance of systemic inflammatory parameters in high-grade
glial tumor patients: Two center experience.
Medicine
(Baltimore). 2024 Apr 19;103(16):e37726. doi:
10.1097/MD.0000000000037726. PMID:
38640334. Observational study. ˍ
|
|
|
|
Zinsz A, Pouget C, Rech F, Taillandier L, Blonski M, Amlal S,
Imbert L, Zaragori T, Verger A.
The
role of [18 F]FDOPA PET as an adjunct to conventional MRI in the
diagnosis of aggressive glial lesions.
Eur
J Nucl Med Mol Imaging. 2024 Apr 19. doi:
10.1007/s00259-024-06720-y. PMID:
38637354. Observational study˰
ˍ
|
|
|
|
Reynolds JA, Pecorari IL, Ledet A, Agarwal V.
High-Grade
Glioma Recurrence Is Delayed in Hispanic Patients despite Severe
Social Vulnerability: A Retrospective Cohort Study.
Cancers
(Basel). 2024 Apr 20;16(8):1579. doi:
10.3390/cancers16081579. PMID:
38672661. Observational study. ˍ
|
|
|
|
Choi
YY, Lee M, Kim EH, Lee JE, Jung I, Cheong JH.
Risk
of Subsequent Primary Cancers Among Adult-Onset 5-Year Cancer
Survivors in South Korea: Retrospective Cohort Study.
JMIR
Public Health Surveill.
2024 Apr 21;10:e48380. doi:
10.2196/48380. PMID:
38717807. Observational study. ˍ
|
|
|
|
Lindsay HB, Scheurer ME, Allam AK, Lucas BJ, McGovern SL,
Chintagumpala M, Paulino AC.
Late-onset
lymphopenia during radiation is associated with an increased risk
of tumor recurrence in newly diagnosed pediatric
medulloblastoma.
Pediatr
Blood Cancer. 2024 Apr 21:e31022. doi:
10.1002/pbc.31022. PMID:
38644606. Observational study˰
ˍ
|
|
|
|
Liu C, Kuang S, Huang T, Wu J, Zhang L, Gong X.
Radiotherapy
plus temozolomide with or without anlotinib in H3K27M-mutant
diffuse midline glioma: A retrospective cohort study.
CNS
Neurosci Ther. 2024 Apr 21;30(4):e14730. doi:
10.1111/cns.14730. PMID:
38644565. Observational study. ˍ
|
|
|
|
McKean
WB, Yang J, Boucher K, Shrieve DC, Suneja G, Salzman K, Jensen R,
Colman H, Cohen AL.
D-TERMINED,
a phase 1 trial in newly diagnosed high-grade glioma with
temozolomide, radiation, and minocycline followed by adjuvant
minocycline/temozolomide.
Neurooncol
Adv.
2024 Apr 23;6(1):vdae063. doi:
10.1093/noajnl/vdae063. PMID:
38800698. Interventional study. ˍ
|
|
|
|
Okamoto T, Mizuta R, Takahashi Y, Otani Y, Sasaki E, Horio Y,
Kuroda H, Matsushita H, Date I, Hashimoto N, Masago K.
Genomic
landscape of glioblastoma without IDH somatic mutation in 42
cases: a comprehensive analysis using RNA sequencing data.
J
Neurooncol. 2024 Apr 23. doi:
10.1007/s11060-024-04628-z. PMID:
38653957. Laboratory investigation˰
ˍ
|
|
|
|
Takano S, Tomita N, Kuno M, Niwa M, Torii A, Takaoka T, Kita N,
Okazaki D, Yamamoto S, Kawai T, Sugie C, Ogawa Y, Matsumoto K,
Uchiyama K, Otsuka S, Matsui T, Miyakawa A, Mizuno T, Iida M,
Tanikawa M, Mase M, Hiwatashi A.
Simultaneous
boost radiotherapy versus conventional dose radiotherapy for
patients with newly diagnosed glioblastoma: a multi-institutional
analysis.
Sci
Rep. 2024 Apr 23;14(1):9283. doi:
10.1038/s41598-024-60154-y. PMID:
38654028. Observational study. ˍ
|
|
|
|
Poklepovic AS, Shah P, Tombes MB, Shrader E, Bandyopadhyay D, Deng
X, Roberts CH, Ryan AA, Hudson D, Sankala H, Kmieciak M, Dent P,
Malkin MG.
Phase 2 Study of Sorafenib,
Valproic Acid, and Sildenafil in the Treatment of Recurrent
High-Grade Glioma.
medRxiv
[Preprint]. 2024 Apr 24:2024.04.23.24304634. doi:
10.1101/2024.04.23.24304634. PMID:
38712133. Interventional study. ˍ
|
|
|
|
Zhou S, Wu S, Li Z, Wang X.
Construction
and Validation of Nomograms for Predicting Overall Survival and
Cancer-Specific Survival in Patients with Primary Anaplastic
Oligodendroglioma.
World
Neurosurg. 2024 Apr 25:S1878-8750(24)00684-3. doi:
10.1016/j.wneu.2024.04.111. PMID:
38677647. Observational study˰
ˍ
|
|
|
|
Doron O, Wong T, Ablyazova F, Singha S, Cavallaro J, Ben-Shalom N,
D'Amico RS, Harshan M, McKeown A, Zlochower A, Langer DJ, Boockvar
JA.
Results from a first-in-human phase
i safety trial to evaluate the use of a vascularized
pericranial/temporoparietal fascial flap to line the resection
cavity following resection of newly diagnosed glioblastoma.
J
Neurooncol. 2024 Apr 26. doi:
10.1007/s11060-024-04647-w. PMID:
38664311. Interventional study. ˍ
|
|
|
|
Engelhardt M, Schneider H, Reuther J, Grittner U, Vajkoczy P,
Picht T, Rosenstock T.
Low-frequency
repetitive transcranial magnetic stimulation in patients with
motor deficits after brain tumor resection: a randomized,
double-blind, sham-controlled trial.
Front
Oncol. 2024 Apr 26;14:1368924. doi:
10.3389/fonc.2024.1368924. PMID:
38737898. Interventional study. ˍ
|
|
|
|
McDonald AM, Murdaugh DL, Heinzman KA, Cardan RA, Jacob J, Fiveash
JB, Nabors LB, Cooper CA, Hoyle JM, Milner D, Cardenas
CE.
Longitudinal brain volumetrics in
glioma survivors.
J
Neurosurg. 2024 Apr 26:1-8. doi:
10.3171/2024.1.JNS231980. PMID:
38669700. Observational study˰
ˍ
|
|
|
|
Xing
Z, Wang C, Yang W, She D, Yang X, Cao D.
Predicting
glioblastoma recurrence using multiparametric MR imaging of
non-enhancing peritumoral regions at baseline.
Heliyon.
2024 Apr 26;10(9):e30411. doi:
10.1016/j.heliyon.2024.e30411. PMID:
38711642. Observational study. ˍ
|
|
|
|
Keul J, Sperling S, Rohde V, Mielke D, Ninkovic M.
Riluzole
Reverses a Number of Undesirable Effects of Dexamethasone in
Glioblastoma Cells.
Anticancer
Res. 2024 Apr 27;44(5):1829-1835. doi:
10.21873/anticanres.16984. PMID:
38677733. Laboratory investigation. ˍ
|
|
|
|
Tropeano MP, Raspagliesi L, Bono BC, Baram A, Rossini Z, Franzini
A, Navarria P, Clerici E, Bellu L, Simonelli M, Scorsetti M, Riva
M, Politi LS, Pessina F.
Supramaximal
resection: retrospective study on IDH-wildtype Glioblastomas based
on the new RANO-Resect classification.
Acta
Neurochir (Wien). 2024 Apr 27;166(1):196. doi:
10.1007/s00701-024-06090-2. PMID:
38676720. Observational study˰
ˍ
|
|
|
|
Wang F, Zhu Y, Wanggou S, Lin D, Su J, Li X, Tao E.
A
natural compound melatonin enhances the effects of Nimotuzumab via
inhibiting EGFR in glioblastoma.
Cancer
Lett. 2024 Apr 27:216920. doi:
10.1016/j.canlet.2024.216920. PMID:
38679408. Laboratory investigation. ˍ
|
|
|
|
Sokol Z, Parsells P, Madineni R.
Liponeurocytoma:
Rare Neoplasm of the Central Nervous System.
Cureus.
2024 Apr 28;16(4):e59221. doi:
10.7759/cureus.59221. PMID:
38807804. Case report. ˍ
|
|
|
|
Bashour G, Ismaiel N, Ebrahim Y, Ibrahim M, Deeb T, Khatab K, Ali
MS, Alshehabi Z.
Primary spinal
oligodendroglioma with intracranial extension: a case report.
Ann
Med Surg (Lond). 2024 Apr 29;86(6):3757-3761. doi:
10.1097/MS9.0000000000002099. PMID:
38846823. Case report. ˍ
|
|
|
|
Gerritsen JKW, Young JS, Chang SM, Krieg SM, Jungk C, van den Bent
MJ, Satoer DD, Ille S, Schucht P, Nahed BV, Broekman MLD, Berger
M, De Vleeschouwer S, Vincent AJPE.
SUPRAMAX-study:
supramaximal resection versus maximal resection for glioblastoma
patients: study protocol for an international multicentre
prospective cohort study (ENCRAM 2201).
BMJ
Open. 2024 Apr 29;14(4):e082274. doi:
10.1136/bmjopen-2023-082274. PMID:
38684246. Interventional study protocol. ˍ
|
|
|
|
Gongala S, Garcia JA, Korakavi N, Patil N, Akbari H, Sloan A,
Barnholtz-Sloan JS, Sun J, Griffith B, Poisson LM, Booth TC, Jain
R, Mohan S, Nasralla MP, Bakas S, Tippareddy C, Puig J, Palmer JD,
Shi W, Colen RR, Sotiras A, Ahn SS, Park YW, Davatzikos C, Badve
C.
Sex-specific Differences in
IDH1-Wildtype Glioblastoma patients in the ReSPOND
Consortium.
AJNR
Am J Neuroradiol. 2024 Apr 29:ajnr.A8319. doi:
10.3174/ajnr.A8319. PMID:
38684319. Observational study˰
ˍ
|
|
|
|
*Huang
M, Liu Y, Peng J, Cheng Y.
Causal
effects of immune cells in glioblastoma: a Bayesian Mendelian
Randomization study.
Front
Neurol.
2024 Apr 29;15:1375723. doi:
10.3389/fneur.2024.1375723. PMID:
38742049. Laboratory investigation. ˍ
|
|
|
|
Jung
K, Kempter J, Prokop G, Herrmann T, Griessmair M, Kim SH,
Delbridge C, Meyer B, Bernhardt D, Combs SE, Zimmer C, Wiestler B,
Schmidt-Graf F, Metz MC.
Quantitative
Assessment of Tumor Contact with Neurogenic Zones and Its Effects
on Survival: Insights beyond Traditional Predictors.
Cancers
(Basel).
2024 Apr 29;16(9):1743. doi:
10.3390/cancers16091743. PMID:
38730694. Observational study. ˍ
|
|
|
|
*Pichol-Thievend C, Anezo O, Pettiwala AM, Bourmeau G, Montagne R,
Lyne AM, Guichet PO, Deshors P, Ballestín A, Blanchard B,
Reveilles J, Ravi VM, Joseph K, Heiland DH, Julien B, Leboucher S,
Besse L, Legoix P, Dingli F, Liva S, Loew D, Giani E, Ribecco V,
Furumaya C, Marcos-Kovandzic L, Masliantsev K, Daubon T, Wang L,
Diaz AA, Schnell O, Beck J, Servant N, Karayan-Tapon L, Cavalli
FMG, Seano G.
VC-resist glioblastoma
cell state: vessel co-option as a key driver of chemoradiation
resistance.
Nat
Commun. 2024 Apr 29;15(1):3602. doi:
10.1038/s41467-024-47985-z. PMID:
38684700. Laboratory investigation. ˍ
|
|
|
|
*Wang
J, Hao Z, Li R, Wu W, Huang N, Zhang K, Hao S, Feng J, Chu J, Ji
N.
Association
of body mass index with clinical outcome of primary WHO grade 4
glioma.
Front
Oncol.
2024 Apr 29;14:1318785. doi:
10.3389/fonc.2024.1318785. PMID:
38741777. Observational study. ˍ
|
|
|
|
Dono A, Zhu P, Takayasu T, Arevalo O, Riascos R, Tandon N,
Ballester LY, Esquenazi Y.
Extent of
Resection Thresholds in Molecular Subgroups of Newly Diagnosed
Isocitrate Dehydrogenase-Wildtype Glioblastoma.
Neurosurgery.
2024 Apr 30. doi:
10.1227/neu.0000000000002964. PMID:
38687046. Observational study˰
ˍ
|
|
|
|
Ishaq HM, Yasin R, Mohammad IS, Fan Y, Li H, Shahzad M, Xu J.
The
gut-brain-axis: A positive relationship between gut microbial
dysbiosis and glioblastoma brain tumour.
Heliyon.
2024 Apr 30;10(9):e30494. doi:
10.1016/j.heliyon.2024.e30494. PMID:
38756585. Laboratory investigation. ˍ
|
|
|
|
Ngai
CH, Teo C, Foo JY, Lim S, Koh JQS, Chan HM, Loh NW, Teo
K.
Application
of a Standardized Treatment Paradigm as a Strategy to Achieve
Optimal Onco-Functional Balance in Glioma Surgery.
Brain
Tumor Res Treat.
2024 Apr 30;12(2):100-108. doi:
10.14791/btrt.2024.0011. PMID:
38742258. Observational study. ˍ
|
|
|
|
O'Halloran
K, Margol A, Davidson TB, Estrine D, Tamrazi B, Cotter JA, Ji J,
Biegel JA.
Disease
Evolution Monitored by Serial Cerebrospinal Fluid Liquid Biopsies
in Two Cases of Recurrent Medulloblastoma.
Int
J Mol Sci.
2024 Apr 30;25(9):4882. doi:
10.3390/ijms25094882. PMID:
38732099. Case report. ˍ
|
|
|
|
Rivas
SR, Mendez Valdez MJ, Chandar JS, Desgraves JF, Lu VM, Ampie L,
Singh EB, Seetharam D, Ramsoomair CK, Hudson A, Ingle SM,
Govindarajan V, Doucet-O'Hare TT, DeMarino C, Heiss JD, Nath A,
Shah AH.
Antiretroviral
Drug Repositioning for Glioblastoma.
Cancers
(Basel).
2024 Apr 30;16(9):1754. doi:
10.3390/cancers16091754. PMID:
38730705. Laboratory investigation. ˍ
|
|
|
|
Sarmiento
JVM, Casis RM, Opinaldo PVA.
Understanding
the Brain-Heart Connection Through a Case of Angry Glioma
Syndrome.
Brain
Tumor Res Treat.
2024 Apr 30;12(2):121-124. doi:
10.14791/btrt.2024.0004. PMID:
38742261. Case report. ˍ
|
|
|
|
Sato
M, Han Q, Mizuta K, Mori R, Kang BM, Morinaga S, Kobayashi N,
Ichikawa Y, Nakajima A, Hoffman RM.
Extensive
Shrinkage and Long-term Stable Disease in a Teenage Female Patient
With High-grade Glioma Treated With Temozolomide and Radiation in
Combination With Oral Recombinant Methioninase and a
Low-methionine Diet.
In
Vivo.
2024 Apr 30;38(3):1459-1464. doi:
10.21873/invivo.13591. PMID:
38688589. Case report. ˍ
|
|
|
|
|
|
|
|
|
|
|
Topics
|
|